Charles M Norris Jr
Overview
Explore the profile of Charles M Norris Jr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
680
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sher D, Thotakura V, Balboni T, Norris Jr C, Haddad R, Posner M, et al.
Int J Radiat Oncol Biol Phys
. 2011 May;
81(4):e215-22.
PMID: 21531515
Purpose: The optimal management of oral cavity squamous cell carcinoma (OCSCC) typically involves surgical resection followed by adjuvant radiotherapy or chemoradiotherapy (CRT) in the setting of adverse pathologic features. Intensity-modulated...
2.
Sher D, Balboni T, Haddad R, Norris Jr C, Posner M, Wirth L, et al.
Int J Radiat Oncol Biol Phys
. 2010 Dec;
80(5):1405-11.
PMID: 21177045
Purpose: No single standard treatment paradigm is available for head-and-neck squamous cell carcinoma of an unknown primary (HNCUP). Bilateral neck radiotherapy with mucosal axis irradiation is widely used, with or...
3.
Schoenfeld J, Sher D, Norris Jr C, Haddad R, Posner M, Balboni T, et al.
Int J Radiat Oncol Biol Phys
. 2010 Nov;
82(1):308-14.
PMID: 21075557
Purpose: To analyze the recent single-institution experience of patients with salivary gland tumors who had undergone adjuvant intensity-modulated radiotherapy (IMRT), with or without concurrent chemotherapy. Patients And Methods: We performed...
4.
Sher D, Haddad R, Norris Jr C, Posner M, Wirth L, Goguen L, et al.
Cancer
. 2010 Jun;
116(20):4761-8.
PMID: 20572036
Background: Patients with locally recurrent squamous cell cancer of the head and neck (SCCHN) are reported to have a poor prognosis and limited therapeutic options. Optimal management is selectively applied...
5.
Lindholm P, Norris Jr C, Braver J, Jacobson F, Ferrigno M
Respir Physiol Neurobiol
. 2009 Apr;
167(2):189-94.
PMID: 19383557
Glossopharyngeal breathing, frequently performed by elite breath-hold divers, relies on muscles of the mouth and pharynx to move air into (glossopharyngeal insufflation, GI) and out of the lungs (glossopharyngeal exsufflation,...
6.
Wirth L, Krane J, Li Y, Othus M, Moran A, Dorfman D, et al.
Cancer Prev Res (Phila)
. 2009 Jan;
1(5):339-48.
PMID: 19138978
This study evaluated changes in prostaglandin E(2) (PGE(2)) levels and related biomarkers in oral premalignant lesions (OPL) in response to celecoxib treatment. Twenty-two subjects were enrolled and treated with celecoxib....
7.
Posner M, Hershock D, Blajman C, Mickiewicz E, Winquist E, Gorbounova V, et al.
N Engl J Med
. 2007 Oct;
357(17):1705-15.
PMID: 17960013
Background: A randomized phase 3 trial of the treatment of squamous-cell carcinoma of the head and neck compared induction chemotherapy with docetaxel plus cisplatin and fluorouracil (TPF) with cisplatin and...
8.
Tishler R, Posner M, Norris Jr C, Mahadevan A, Sullivan C, Goguen L, et al.
Int J Radiat Oncol Biol Phys
. 2006 May;
65(4):1036-44.
PMID: 16682134
Purpose: In a Phase I/II trial, we investigated concurrent weekly docetaxel and concomitant boost radiation in patients with locally advanced squamous cell cancer of the head and neck (SCCHN) after...
9.
Haddad R, Posner M, Busse P, Norris Jr C, Goguen L, Wirth L, et al.
Am J Clin Oncol
. 2006 Apr;
29(2):153-7.
PMID: 16601434
Objectives: A retrospective review of primary chemoradiotherapy (CRT) for adenoid cystic carcinoma (ACC) was performed to determine if CRT might be considered as an alternative to radiotherapy and/or definitive surgery....
10.
Wirth L, Haddad R, Lindeman N, Zhao X, Lee J, Joshi V, et al.
J Clin Oncol
. 2005 Sep;
23(28):6976-81.
PMID: 16172459
Purpose: Effective and tolerable palliative treatments are needed for patients with incurable squamous cell carcinoma of the head and neck (SCCHN). Single-agent targeted therapies have limited activity in this setting....